MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

11 Oct 2021 Evaluate

Glenmark Pharmaceuticals has informed that it attached media release dated October 11, 2021 titled ‘Glenmark launches Tavulus® for COPD treatment in Spain, becoming one of the first companies to launch a bioequivalent version of the dry powder inhaler’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..